Klamin

Nutrigea is a biotechnology and nutraceutical company specializing in the research and development of bioactive extracts derived from Aphanizomenon flos-aquae (AFA) microalgae. The company is best known for its patented extract, Klamin, which is concentrated in phenylethylamine (PEA) and other neuro-modulating molecules designed to support mental health and cognitive function. Nutrigea's business model focuses on the clinical validation of its proprietary extracts for indications such as ADHD, mood disorders, and menopausal symptoms. Through its research arm, Nutrigea Research, the company conducts clinical trials to establish the efficacy of its algae-based molecules as natural alternatives to traditional pharmaceuticals. Their products are distributed globally, targeting the intersection of nutrition and therapeutic intervention.